Trials / Conditions / Clear Cell Sarcoma of the Kidney
Clear Cell Sarcoma of the Kidney
6 registered clinical trials studyying Clear Cell Sarcoma of the Kidney.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced NCT01154452 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Biomarkers in Tissue Samples From Patients With High-Risk Wilms Tumor NCT01118078 | Children's Oncology Group | — |
| Completed | Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastat NCT01061411 | Roswell Park Cancer Institute | Phase 1 |
| Completed | Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery NCT01553539 | Wake Forest University Health Sciences | Phase 2 |
| Completed | Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors NCT00335556 | Children's Oncology Group | Phase 2 |
| Active Not Recruiting | Study of Kidney Tumors in Younger Patients NCT00898365 | Children's Oncology Group | — |